RAZTROL Tablet Ref.[50495] Active ingredients: Rupatadine

Source: Health Products Regulatory Authority (ZA)  Revision Year: 2021  Publisher: RANBAXY PHARMACEUTICALS (PTY) LTD, 14 Lautre Road, Stormill, Ext. 1, Roodepoort, 1724, South Africa

4.1. Therapeutic indications

Symptomatic treatment of allergic rhinitis and urticaria in adults and adolescents (over 12 years of age).

4.2. Posology and method of administration

Posology

Adults and adolescents (over 12 years of age)

The recommended dose is 10 mg (one tablet) once a day, with or without food.

Method of Administration

For oral use.

4.9. Overdose

Should overdose occur, treatment should be symptomatic or supportive, taking into account any concomitantly ingested medications.

6.3. Shelf life

24 Months.

6.4. Special precautions for storage

Store at or below 30⁰C. Keep the blister in the outer carton in order to protect from light.

KEEP OUT OF THE REACH OF CHILDREN.

6.5. Nature and contents of container

RAZTROL tablets are packed in blister packs consisting of PVC/PVDC foil as a forming material and pre-printed aluminium foil as a lidding material. Each blister will contain 10 tablets. Blisters are packed in a carton in pack sizes of 10, 20 or 30 tablets.

6.6. Special precautions for disposal and other handling

No special requirement for disposal.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.